Varonis Acquisition Fuels Record Year for Israeli Cybersecurity Exits
Translated & summarized from Globes by baba
Cybersecurity firm Varonis has been acquired for $6.3 billion, marking a significant event in a record year for Israeli cybersecurity exits totaling over $71 billion. This trend is driven by AI's impact on threat landscapes and defense needs, leading to industry consolidation. Analysts predict further major exits, with Cato being a potential candidate. While Israeli institutional investors hold minimal stakes, the acquisition highlights the sector's growth and strategic importance.
The story in 5 lines · by baba
- Varonis acquired for $6.3 billion, contributing to over $71 billion in Israeli cybersecurity exits this year.
- The surge in exits is driven by AI's impact on threat landscapes and evolving defense needs.
- Analysts predict continued consolidation and potential future exits, with Cato identified as a candidate.
- Israeli institutional investors hold minimal stakes in Varonis, with major gains for BlackRock.
- The merged Varonis-Proofpoint entity aims for $3.5 billion in ARR and market dominance in AI Security.
The Israeli cybersecurity sector is experiencing a historic year, marked by the recent acquisition of Varonis by Proofpoint for $6.3 billion. This deal follows a series of major exits, including Wiz's $32 billion sale to Google, CyberArk's $25 billion sale to Palo Alto, and Armis's $7.75 billion sale to ServiceNow. Combined, these transactions, including Varonis, total over $71 billion in exits this year alone, with expectations of more to come.
Rody Shaty, manager of foreign stock research at IBI, had predicted Varonis would be the next major exit and now sees continued consolidation in the cybersecurity industry. He attributes this trend to evolving needs driven by AI, which is dramatically altering the threat landscape and increasing the criticality of defense requirements for companies. Shaty noted a shift in market perception, where initial fears that AI would harm cybersecurity stocks have been replaced by an understanding that AI also drives aggressive growth in the sector, leading to significant double-digit stock increases.
Looking ahead, Shaty identifies Cato, founded by Shlomo Kramer, as a potential next major exit. He highlights Israel's strong cybersecurity ecosystem, stemming from military experience in units like 8200 and 81, as a driver for future startup success. While Kramer has reportedly been hesitant to sell Cato, Shaty suggests a substantial offer from companies like Microsoft or Palo Alto could be too attractive to refuse, following the precedent set by the large acquisitions of Wiz and CyberArk.
The Varonis sale will have a minimal impact on Israeli institutional investors, who hold a negligible portion of the company's shares. Varonis, founded in Israel in 2004 by Yaki Feitelson and Ohad Korkus, has been a US-registered company trading on Nasdaq since its 2014 IPO. While major investors like BlackRock stand to gain significantly, Israeli institutions like Clal Insurance and Menora hold stakes valued at approximately $72.6 million and $21 million, respectively. The founders, Feitelson and Korkus, will see their stakes valued at around $42 million and $6.3 million, respectively.
Despite past disappointments, such as Varonis's lowered forecasts in late 2025 which caused a nearly 50% stock drop, the company's recent performance and strategic focus on AI security have made it an attractive acquisition target. The deal, priced at $49.75 per share, reflects a 7.8x forward revenue multiple. The merged entity aims to achieve $3.5 billion in annual recurring revenue (ARR) and eventually reach $5 billion, with a stated goal of dominating the AI Security market and returning to the public market as a larger company.
Mentioned
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Centre 1Other 3
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.
